Bottom line
SPXV vs XLV: the short answer
SPXV (ProShares S&P 500 Ex-Health Care ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
But SPXV is far broader, holding 449 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 0.09% — a difference of $1.00 a year per $10,000 invested.
Over five years, SPXV returned +15.1% a year vs +8.1% for XLV.
Updated Nov 19, 2026
SPXV vs XLV side by side
| SPXV | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | ProShares | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.08% |
| Annual cost per $10k | $9 | $8 |
| 10-yr cost on $10k (prospectus) | $162 | $103 |
| Max front load | None | None |
| 12b-1 fee | — | 0.02% |
| 1-yr return | +18.1% | +14.5% |
| 5-yr return (annualized) | +15.1% | +8.1% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | +21.7% | +14.5% |
| Worst quarter | −20.7% | −12.7% |
| Net assets (fund) | $40.2M | $40.6B |
| Number of holdings | 449 | 65 |
| Portfolio turnover | 4% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SPXV | XLV | Difference |
|---|---|---|---|
| 2025 | +18.1% | +14.5% | +3.6% |
| 2024 | +28.0% | +2.5% | +25.5% |
| 2023 | +30.7% | +2.0% | +28.7% |
| 2022 | −20.6% | −2.1% | −18.5% |
| 2021 | +28.7% | +25.9% | +2.7% |
| 2020 | +18.9% | +13.3% | +5.7% |
| 2019 | +33.0% | +20.7% | +12.3% |
| 2018 | −6.4% | +6.3% | −12.7% |
| 2017 | +21.4% | +21.7% | −0.3% |
| 2016 | +14.2% | −2.8% | +17.0% |
Source: Fund prospectus bar charts
Holdings overlap
SPXV and XLV share none of their top holdings.
SPXV top 10
- NVIDIA Corp. — 8.60%
- Apple, Inc. — 7.68%
- Microsoft Corp. — 5.60%
- Amazon.com, Inc. — 4.43%
- Alphabet, Inc. — 3.71%
- Broadcom, Inc. — 3.55%
- Alphabet, Inc. — 2.95%
- Meta Platforms, Inc. — 2.32%
- Tesla, Inc. — 2.05%
- Micron Technology, Inc. — 1.83%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between SPXV and XLV?
Which is cheaper, SPXV or XLV?
Should I own both SPXV and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.